| # | Title | Journal | Year | Citations |
|---|
| 1 | ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD | Cardiovascular Therapy and Prevention (Russian Federation) | 2014 | 161 |
| 2 | THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RUSSIAN POPULATION IN 2012-2013 YEARS. THE RESULTS OF ECVD-RF | Cardiovascular Therapy and Prevention (Russian Federation) | 2014 | 154 |
| 3 | Comorbidities in clinical practice. Algorithms for diagnostics and treatment | Cardiovascular Therapy and Prevention (Russian Federation) | 2019 | 126 |
| 4 | COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES | Cardiovascular Therapy and Prevention (Russian Federation) | 2017 | 74 |
| 5 | Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020 | Cardiovascular Therapy and Prevention (Russian Federation) | 2020 | 60 |
| 6 | Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice | Cardiovascular Therapy and Prevention (Russian Federation) | 2016 | 56 |
| 7 | Psychoemotional risk factors for non-communicable diseases in outpatient practice. Guidelines for internists | Cardiovascular Therapy and Prevention (Russian Federation) | 2022 | 53 |
| 8 | Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 47 |
| 9 | Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 46 |
| 10 | Economic burden of cardiovascular disease in the Russian Federation | Cardiovascular Therapy and Prevention (Russian Federation) | 2011 | 42 |
| 11 | Demographic trends in the Russian Federation: the impact of cardiovascular disease | Cardiovascular Therapy and Prevention (Russian Federation) | 2012 | 42 |
| 12 | REGISTERS IN CARDIOLOGY: THEIR PRINCIPLES, RULES, AND REAL-WORD POTENTIAL | Cardiovascular Therapy and Prevention (Russian Federation) | 2013 | 40 |
| 13 | TWENTY YEARS TRENDS OF OBESITY AND ARTERIAL HYPERTENSION AND THEIR ASSOCIATION IN RUSSIA | Cardiovascular Therapy and Prevention (Russian Federation) | 2017 | 40 |
| 14 | CARDIOVASCULAR DISEASES REGISTRY (RECVAZA): DIAGNOSTICS, CONCOMITANT CARDIOVASCULAR PATHOLOGY, COMORBIDITIES AND TREATMENT IN THE REAL OUTPATIENT-POLYCLINIC PRACTICE | Cardiovascular Therapy and Prevention (Russian Federation) | 2014 | 37 |
| 15 | SOCIO-ECONOMIC EFFECTIVENESS OF HEALTH SCREENING ACTIVITY IN 2013 IN RUSSIAN FEDERATION | Cardiovascular Therapy and Prevention (Russian Federation) | 2014 | 37 |
| 16 | 2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines | Cardiovascular Therapy and Prevention (Russian Federation) | 2022 | 37 |
| 17 | High-sensitivity cardiac troponins: detection and central analytical characteristics | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 35 |
| 18 | Nutrition characteristics of adult inhabitants by ESSE-RF study | Cardiovascular Therapy and Prevention (Russian Federation) | 2018 | 30 |
| 19 | Comorbidity in chronic obstructive pulmonary disease and cardiovascular disease | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 29 |
| 20 | Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice | Cardiovascular Therapy and Prevention (Russian Federation) | 2016 | 29 |
| 21 | DISTRIBUTION OF LIPID PROFILE VALUES IN ECONOMICALLY ACTIVE MEN AND WOMEN IN RUSSIAN FEDERATION: RESULTS OF THE ESSE-RF STUDY FOR THE YEARS 2012-2014 | Cardiovascular Therapy and Prevention (Russian Federation) | 2017 | 29 |
| 22 | Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study) | Cardiovascular Therapy and Prevention (Russian Federation) | 2012 | 28 |
| 23 | AWARENESS AND TREATMENT SPECIFICS OF STATIN THERAPY IN PERSONS WITH VARIOUS CARDIOVASULAR RISK: THE STUDY ESSE-RF | Cardiovascular Therapy and Prevention (Russian Federation) | 2016 | 27 |
| 24 | High-sensitivity cardiac troponins: circadian rhythms | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 24 |
| 25 | What factors do influence arterial hypertension control in Russia | Cardiovascular Therapy and Prevention (Russian Federation) | 2018 | 24 |
| 26 | Adherence to a healthy lifestyle of the Russian population depending on the socio-demographics | Cardiovascular Therapy and Prevention (Russian Federation) | 2020 | 24 |
| 27 | Contribution of the ESSE-RF study to preventive healthcare in Russia | Cardiovascular Therapy and Prevention (Russian Federation) | 2020 | 24 |
| 28 | TREATMENT ADHERENCE: MODERN VIEW ON A WELL KNOWN ISSUE | Cardiovascular Therapy and Prevention (Russian Federation) | 2017 | 23 |
| 29 | Epidemiology of Cardiovascular Diseases in Regions of Russian Federation. Third survey (ESSE-RF-3). Rationale and study design | Cardiovascular Therapy and Prevention (Russian Federation) | 2022 | 22 |
| 30 | RUSSIAN VERSION OF PHQ-2 AND 9 QUESTIONNAIRES: SENSITIVITY AND SPECIFICITY IN DETECTION OF DEPRESSION IN OUTPATIENT GENERAL MEDICAL PRACTICE | Cardiovascular Therapy and Prevention (Russian Federation) | 2014 | 21 |
| 31 | Subclinical atherosclerosis as a risk factor of cardiovascular events | Cardiovascular Therapy and Prevention (Russian Federation) | 2012 | 21 |
| 32 | Russian mortality trends in the early XXI century: official statistics data | Cardiovascular Therapy and Prevention (Russian Federation) | 2011 | 20 |
| 33 | POLYMORBIDITY: SPECIFICS OF CO-DEVELOPMENT AND CONCOMITANCE OF SEVERAL DISEASES IN ONE PATIENT | Cardiovascular Therapy and Prevention (Russian Federation) | 2016 | 20 |
| 34 | SURGICAL TREATMENT OF MULTIFOCAL ATHEROSCLEROSIS: CORONARY AND BRACHIOCEPHALIC PATHOLOGY AND PREDICTORS OF EARLY ADVERSE EVENTS DEVELOPMENT | Cardiovascular Therapy and Prevention (Russian Federation) | 2017 | 20 |
| 35 | COVID-19: urgent questions for estimating morbidity, prevalence, case fatality rate and mortality rate | Cardiovascular Therapy and Prevention (Russian Federation) | 2020 | 20 |
| 36 | Vascular ageing: main symptoms and mechanisms | Cardiovascular Therapy and Prevention (Russian Federation) | 2012 | 19 |
| 37 | MORTALITY AND LOST YEARS OF LIFE AS A RESULT OF CARDIOVASCULAR PREMATURE DEATHS | Cardiovascular Therapy and Prevention (Russian Federation) | 2014 | 19 |
| 38 | COMORBIDITY: HISTORY, RECENT VIEWS, PREVENTION AND TREATMENT | Cardiovascular Therapy and Prevention (Russian Federation) | 2015 | 19 |
| 39 | Hospital register of patients with acute cerebrovascular accident (REGION): characteristics of patient and outcomes of hospital treatment | Cardiovascular Therapy and Prevention (Russian Federation) | 2018 | 19 |
| 40 | Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes | Cardiovascular Therapy and Prevention (Russian Federation) | 2020 | 19 |
| 41 | Russian Society for the Prevention of Noncommunicable Diseases (ROPNIZ). Alimentary-dependent risk factors for chronic non-communicable diseases and eating habits: dietary correction within the framework of preventive counseling. Methodological Guidelines | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 18 |
| 42 | COMORBIDITIES OF ISCHEMIC HEART DISEASE WITH OTHER NON-COMMUNICABLE DISEASES IN ADULT POPULATION: AGE AND RISK FACTORS ASSOCIATION | Cardiovascular Therapy and Prevention (Russian Federation) | 2015 | 16 |
| 43 | SOCIAL AND ECONOMIC GRADIENTS OF BEHAVIORAL RISK FACTORS IN RUSSIAN POPULATION (BY THE ESSE-RF STUDY) | Cardiovascular Therapy and Prevention (Russian Federation) | 2015 | 16 |
| 44 | Novel coronavirus infection SARS-CoV-2 in elderly and senile patients: prevention, diagnosis and treatment. Expert Position Paper of the Russian Association of Gerontology and Geriatrics | Cardiovascular Therapy and Prevention (Russian Federation) | 2020 | 16 |
| 45 | Contribution of hypertension and other risk factors to survival and mortality in the Russian population | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 15 |
| 46 | SELECTION OF OPTIMAL APPROACHES TO PREVENTION OF NON-COMMUNICABLE DISEASES IN INTERNATIONAL PARTNERSHIP CIRCUMSTANCES | Cardiovascular Therapy and Prevention (Russian Federation) | 2018 | 15 |
| 47 | Comorbidity, multimorbidity, dual diagnosis — synonyms or different terms? | Cardiovascular Therapy and Prevention (Russian Federation) | 2019 | 15 |
| 48 | Metabolic syndrome and its associations with socio-demographic and behavioral risk factors in the Russian population aged 25-64 years | Cardiovascular Therapy and Prevention (Russian Federation) | 2020 | 15 |
| 49 | Role of biobanking in managing large-scale epidemiological studies | Cardiovascular Therapy and Prevention (Russian Federation) | 2021 | 14 |
| 50 | Early left ventricular remodelling criteria and antihypertensive therapy effectiveness | Cardiovascular Therapy and Prevention (Russian Federation) | 2011 | 14 |
